Virtu Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56M Buy
+17,082
New +$1.86M 0.08% 138
2024
Q1
– Sell
-8,620
Closed -$233K – 1649
2023
Q4
$233K Buy
+8,620
New +$226K 0.02% 733
2023
Q2
– Sell
-8,853
Closed -$207K – 1696
2023
Q1
$207K Sell
8,853
-8,448
-49% -$241K 0.02% 734
2022
Q4
$471K Buy
+17,301
New +$792K 0.06% 307
2021
Q1
– Sell
-3,880
Closed -$500K – 1762
2020
Q4
$500K Sell
3,880
-4,323
-53% -$497K 0.05% 439
2020
Q3
$917K Buy
+8,203
New +$750K 0.16% 138
2019
Q4
$504K Sell
6,452
-3,704
-36% -$267K 0.05% 423
2019
Q3
$648K Buy
+10,156
New +$895K 0.05% 413
2019
Q2
– Sell
-5,855
Closed -$449K – 1605
2019
Q1
$449K Buy
+5,855
New +$325K 0.03% 614

Other funds holding GH

Virtu Financial's GH Position: Q2 2026 in Review

Virtu Financial opened a new position in Guardant Health (GH) in Q2 2026: 17,082 shares worth $2.56M. The stake represents 0.08% of the portfolio and ranks #138 among its holdings. This is a return to the name: Virtu Financial previously reported a position in GH as recently as Q4 2023.

Virtu Financial first reported a position in GH in Q1 2019 and has held it in 9 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Virtu Financial held 17,082 shares of Guardant Health worth $2.56M as of Q2 2026.
  • Guardant Health was a new Virtu Financial position in Q2 2026.
  • Guardant Health made up 0.08% of Virtu Financial's portfolio in Q2 2026, its #138 holding.
  • Virtu Financial first reported a position in Guardant Health in Q1 2019 and has held it in 9 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.